Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
Mouly, Stéphane; Bloch, Vanessa; Peoc'h, Katell; Houze, Pascal; Labat, Laurence; Ksouda, Kamilia; Simoneau, Guy; Declèves, Xavier; Bergmann, Jean Francois; Scherrmann, Jean-Michel; Laplanche, Jean-Louis; Lepine, Jean-Pierre; Vorspan, Florence.
Br J Clin Pharmacol
; 79(6): 967-77, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25556837
Methadone Misinformation and Misconceptions.
[The characteristics of crystallization of mixed saliva in patients using heroin and methadone.]
Quality of life among former Soviet Union and Israeli origin methadone users.
Heroin-assisted treatment: has a controversial treatment come of age?.
Methadone Maintenance Therapy and the Dental Patient.
The association of genetic polymorphisms in the κ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance.
Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients.
Response to Letter to the Editor by Ernesto de Bernadis.
Family Related Factors and Concurrent Heroin Use in Methadone Maintenance Treatment in China.
Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort.